Friday, July 22, 2016

Ultra Rare Diseases and the Collaboration Between CROs & Pharma


At the last Partnerships in Clinical Trials in Boston, MA, we sat down with Mike Collins, VP of Global Clinical Operations at Alexion Pharmaceuticals for an interview. At last year's event, Mike presented a session "CRO and Pharma Collaboration to Meet the Need of Patients with Ultra Rare Diseases". Stemming from the topic addressed in his presentation, during this exclusive interview we asked Mike about ultra rare diseases, the treatment options, development of drugs, the research around these diseases and much more.

Every rare disease study is unique. Working with patients in rare diseases poses new and different challenges to both clinical trial sponsors and their CRO partners to ensure successful trial execution starting with the most critical factor – understanding the needs of the patient. Hear from Mike as he sheds light on how a sponsor and CRO can align efforts to successfully execute a global rare disease study.



Interested in learning more? Join us this October for Partnerships in Clinical Trials. Use the VIP code "P2100BLOG" to save $100 - Click here to learn more.




No comments: